NEW STABILITY INDICATING UPLC METHOD FOR SIMULTANEOUS DETERMINATION OF DAPAGLIFLOZIN AND SAXAGLIPTIN

被引:1
作者
Reddy, Y. Surendranath [1 ]
Sankar, D. Gowri [1 ]
机构
[1] AU Visakhapatnam, Aditya Pharm Coll, Dept Pharmaceut Anal, Surampalem 533437, Andhra Pradesh, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2019年 / 10卷 / 07期
关键词
Dapagliflozin; Simultaneous Saxagliptin; Acetonitrile; Buffer; UPLC;
D O I
10.13040/IJPSR.0975-8232.10(7).3311-17
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new precise, selective, accurate and rapid Ultra Performance Liquid Chromatographic stability indicating method has been developed and validated for simultaneous quantitative determination of Dapagliflozin and Saxagliptin in bulk and pharmaceutical dosage form. The chromatographic separation was achieved with HSS 100 x 2.1 mm, 1.8 m size column. The optimized mobile phase consisting of Phosphate buffer: acetonitrile in the ratio of 50:50 v/v. The flow rate was 0.3 mL/min, and eluents were detected at 260 nm using a PDA detector. The retention time of Dapagliflozin and Saxagliptin were found to be 0.900 and 1.119 min respectively. The percentage recoveries for both the molecules were found to be in the range of 98.61 -100.5%. The calibration curve was constructed between peak areas vs. concentration and demonstrated good linearity in the range of (2.5-15 mu g/ml Dapagliflozin and 1.25-7.5 mu g/ml Saxagliptin). Degradation studies were carried for Dapagliflozin and Saxagliptin under various stress conditions such as acid, base, oxidation, thermal, photochemical and UV degradation peaks were resolved effectively.
引用
收藏
页码:3311 / 3317
页数:7
相关论文
共 12 条
  • [1] [Anonymous], 2005, INT C HARMONISATION, P1
  • [2] Asim MS, 2018, J INNOVATIONS APPL P, V3, P1
  • [3] Chhabda P, 2014, INT J RES DEV PHARM, V3, P993
  • [4] Stability indicating HPLC method for the simultaneous determination of dapagliflozin and saxagliptin in bulk and tablet dosage form
    Deepan, Thiyagarajan
    Dhanaraju, Magharla Dasaratha
    [J]. CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2018, 31 (01) : 39 - 43
  • [5] *ICH, 1996, VAL AN PROC METH Q2
  • [6] ICH, 1997, INT C HARM TECHN REQ
  • [7] Mohammad Y., 2015, Asian J. Pharm. Clin. Res, V8, P320
  • [8] Patel P.D., 2018, IJPRS, V7, P9, DOI [10.31638/ijprs.v7.i1.00006, DOI 10.31638/IJPRS.V7.I1.00006]
  • [9] Rao P.S., 2013, International Journal of Pharma Sceinces, V3, P333
  • [10] DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR THE ESTIMATION OF DAPAGLIFLOZIN IN API
    Sanagapati, Manasa
    Dhanalakshmi, K.
    Nagarjunareddy, G.
    Sreenivasa, S.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (12): : 5394 - 5397